Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians - The strong heart study

被引:45
作者
Resnick, HE
Carter, EA
Lindsay, R
Henly, SJ
Ness, FK
Welty, TK
Lee, ET
Howard, BV
机构
[1] MedStar Res Inst, Dept Epidemiol, Hyattsville, MD 20783 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Missouri Breaks Res, Timber Lake, SD USA
[4] Mille Lacs Band Ojibwe Indians, Diabet Program, Milles Lacs, MN USA
[5] Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA
关键词
D O I
10.2337/diacare.27.6.1286
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To compare risk of all-cause and cardiovascular disease (CVD) mortality in people with a lower-extremity amputation (LEA) attributable to diabetes and people without an LEA. RESEARCH DESIGN AND METHODS - The Strong Heart Study is a Study of CVD and its risk factors in 13 American-Indian communities. LEA was ascertained at baseline by direct examination of the legs and feet. Mortality surveillance is complete through 2000. RESULTS - Of 2,108 participants with diabetes at baseline, 134 participants (6.4%) had an LEA. Abnormal ankle-brachial index (53%), albuminuria (87%), and long diabetes duration (mean 19.8 years) were common among diabetic subjects with LEA. Mean diabetes duration among diabetic participants without LEA and in those with toe and below-the-knee amputations was 11.9, 18.6, and 21.1 years, respectively. During 8.7 ( +/-2.9) years of follow-up, 102 of the was with LEA (76%) died from all causes and 35 (26%) died from CVD. Of the 1,974 diabetic participants without LEA at baseline, 604 (31%) died from all causes and 206 (10%) died from CVD. The unadjusted hazard ratios (HRs) for all-cause and CVD mortality in diabetic participants with LEA compared with those without were 4.0 and 4.1, respectively. Adjusting for known and suspected confounders, LEA persisted as a predictor of all-cause (HR 2.2, 95% Cl 1.7-2.9) and CVD mortality (HR 1.9, 95% CI 1.3-2.9). We observed a significant interaction between baseline LEA and sex on CVD mortality, with female sex conferring added risk of CVD mortality. CONCLUSIONS - LEA is a potent predictor of all-cause and CVD mortality in diabetic The combination of female sex and LEA is associated with greater risk of CVD American Indians. mortality than either factor alone.
引用
收藏
页码:1286 / 1293
页数:8
相关论文
共 32 条
[1]   PREVALENCE OF DIAGNOSED DIABETES AND SELECTED RELATED CONDITIONS OF 6 RESERVATIONS IN MONTANA AND WYOMING [J].
ACTON, K ;
ROGERS, B ;
CAMPBELL, G ;
JOHNSON, C ;
GOHDES, D .
DIABETES CARE, 1993, 16 (01) :263-265
[2]   Lower-extremity amputation in diabetes - The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers [J].
Adler, AI ;
Boyko, EJ ;
Ahroni, JH ;
Smith, DG .
DIABETES CARE, 1999, 22 (07) :1029-1035
[3]   A prospective study of risk factors for diabetic foot ulcer - The Seattle diabetic foot study [J].
Boyko, EJ ;
Ahroni, JH ;
Stensel, V ;
Forsberg, RC ;
Davignon, DR ;
Smith, DG .
DIABETES CARE, 1999, 22 (07) :1036-1042
[4]  
CARTER SA, 1985, NONINVASIVE DIAGNOST, P513
[5]   Risk of diabetes-related amputation in South Asians vs. Europeans in the UK [J].
Chaturvedi, N ;
Abbott, CA ;
Whalley, A ;
Widdows, P ;
Leggetter, SY ;
Boulton, AJM .
DIABETIC MEDICINE, 2002, 19 (02) :99-104
[6]   Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO multinational study of vascular disease in diabetes [J].
Chaturvedi, N ;
Stevens, LK ;
Fuller, JH ;
Lee, ET ;
Lu, M .
DIABETOLOGIA, 2001, 44 (Suppl 2) :S65-S71
[7]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[8]  
Fabsitz RR, 1999, AM J EPIDEMIOL, V149, P330
[9]   PREVALENCE OF DIABETES AND ITS COMPLICATIONS IN THE EASTERN BAND OF CHEROKEE INDIANS [J].
FARRELL, MA ;
QUIGGINS, PA ;
ELLER, JD ;
OWLE, PA ;
MINER, KM ;
WALKINGSTICK, ES .
DIABETES CARE, 1993, 16 (01) :253-256
[10]   DIABETIC COMPLICATIONS AMONG AMERICAN-INDIANS OF WASHINGTON, OREGON, AND IDAHO - PREVALENCE OF RETINOPATHY, END-STAGE RENAL-DISEASE, AND AMPUTATIONS [J].
FREEMAN, WL ;
HOSEY, GM .
DIABETES CARE, 1993, 16 (01) :357-360